Constellium SE CSTM R2K
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the aerospace, packaging, automotive, commercial transportation, general industrial, and defense end-markets. It operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry. The Packaging & Automotive Rolled Products segment produces and develops rolled aluminum products, including canstock and closure stock for the beverage and food industry, as well as foil stock for the flexible packaging market. This segment also supplies automotive body sheets, heat exchangers, and battery foil products for the automotive market. The Aerospace & Transportation segment provides aluminum products including plate, sheet, and extrusions to aerospace, space, commercial transportation, general industrial, and defense sectors. The Automotive Structures & Industry segment offers structural solutions for the automotive industry including crash management systems, body structures, side impact beams, and battery enclosure components; soft and hard alloy extrusions for automotive, transportation, and general industrial applications; and profiles for rail and general industrial applications. This segment also provides downstream technology and services, which include pre-machining, surface treatment, research and development, and technical support services. It sells its products directly or through distributors in France, Germany, the Czech Republic, the United Kingdom, Switzerland, and the United States, as well as South Korea, Japan and China. The company was incorporated in 2010 and is headquartered in Paris, France.
READ MORE ›Market & Price
Valuation
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Growth (CAGR)
PROS
- Strong return on equity of 45.7%.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -0.3% CAGR over 5 years.
- Earnings shrank at -3.9% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CSTM Constellium SE R2K | 34.26 | 10.95 | $4.66B | - | 14.45% | 45.65% | -0.33% | -3.94% |
| 2 | LIN Linde plc NDXSPX | 497.69 | 33.00 | $230.11B | 1.29% | 13.07% | 18.23% | 0.62% | 18.48% |
| 3 | NEM Newmont Corporation SPX | 109.81 | 14.24 | $117.23B | 0.95% | 22.51% | 25.83% | 23.91% | 583.84% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 65.71 | 34.77 | $94.46B | 0.91% | 12.93% | 15.63% | 4.39% | -14.02% |
| 5 | SHW The Sherwin-Williams Company SPX | 303.84 | 29.16 | $74.94B | 1.05% | 20.04% | 60.72% | 2.10% | 8.34% |
| 6 | CRH CRH plc SPX | 108.79 | 20.18 | $72.69B | 1.43% | 11.33% | 15.81% | 4.60% | -1.15% |
| 7 | ECL Ecolab Inc. SPX | 256.00 | 34.59 | $72.05B | 1.14% | 14.89% | 22.43% | 4.26% | 23.88% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 278.62 | 29.33 | $62.04B | 2.60% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | NUE Nucor Corporation SPX | 250.00 | 24.80 | $56.94B | 0.90% | 8.80% | 12.29% | -7.84% | -38.80% |
Quarterly Results
Figures in USD.
| Metric | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.88B | 1.93B | - | - | 1.98B | 2.10B | 2.17B | 2.20B | 2.46B |
| Cost of Revenue | - | - | - | - | 1.72B | 1.84B | 1.85B | 1.85B | 2.04B |
| Gross Profit | - | - | - | - | 263.00M | 263.00M | 314.00M | 347.00M | 420.00M |
| Operating Expenses | - | - | - | - | 166.00M | 178.00M | 181.00M | 181.00M | 190.00M |
| Operating Income | - | - | - | - | 97.00M | 85.00M | 133.00M | 166.00M | 230.00M |
| EBITDA | - | - | - | - | 141.00M | 165.00M | 237.00M | 276.00M | 356.00M |
| Interest Expense | - | - | - | - | 1.00M | 27.00M | 27.00M | 26.00M | 1.00M |
| Pretax Income | - | - | - | - | 62.00M | 56.00M | 126.00M | 164.00M | 272.00M |
| Tax Provision | - | - | - | - | 24.00M | 20.00M | 38.00M | 51.00M | 76.00M |
| Net Income | 21.00M | 76.00M | - | - | 37.00M | 36.00M | 88.00M | 112.00M | 199.00M |
| Diluted EPS | 0.14 | 0.51 | - | -0.34 | 0.26 | 0.25 | 0.62 | - | 1.47 |
| R&D Expense | 15.00M | 13.00M | 11.00M | - | 13.00M | 12.00M | 12.00M | - | 13.00M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 8.53B | 7.83B | 7.33B | 8.45B |
| Cost of Revenue | - | 7.57B | 6.77B | 6.40B | 7.26B |
| Gross Profit | - | 963.00M | 1.05B | 938.00M | 1.19B |
| Operating Expenses | - | 620.00M | 669.00M | 666.00M | 713.00M |
| Operating Income | - | 343.00M | 386.00M | 272.00M | 474.00M |
| EBITDA | - | 539.00M | 639.00M | 542.00M | 844.00M |
| Interest Expense | - | 99.00M | 107.00M | 103.00M | 106.00M |
| Pretax Income | - | 150.00M | 232.00M | 135.00M | 408.00M |
| Tax Provision | - | -165.00M | 75.00M | 75.00M | 133.00M |
| Net Income | - | 308.00M | 152.00M | 56.00M | 273.00M |
| Diluted EPS | - | 2.21 | 0.93 | 0.38 | 1.92 |
| R&D Expense | - | 46.00M | 52.00M | 49.00M | 51.00M |
Compounded Sales Growth
| 5 Years: | -0.33% |
| 1 Year: | 24.40% |
Compounded Profit Growth
| 5 Years: | -3.94% |
| 1 Year: | 446.90% |
Stock Price Performance
| 1 Year: | +182.21% |
| 6 Months: | +112.80% |
| 3 Months: | +37.65% |
| 1 Month: | +6.30% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 5.30B | 4.93B | 4.73B | 5.35B |
| Current Assets | - | 2.22B | 1.99B | 1.83B | 2.32B |
| Cash & Equivalents | - | 152.28M | 223.00M | 141.00M | 120.00M |
| Inventory | - | 1.42B | 1.20B | 1.18B | 1.41B |
| Receivables | - | 498.66M | 418.00M | 381.00M | 611.00M |
| Total Liabilities | - | 4.49B | 4.19B | 4.01B | 4.38B |
| Current Liabilities | - | 1.83B | 1.56B | 1.45B | 1.80B |
| Long Term Debt | - | 2.05B | 1.89B | 1.88B | 1.91B |
| Total Debt | - | 2.20B | 1.95B | 1.92B | 1.94B |
| Total Equity | - | 783.92M | 718.00M | 706.00M | 952.00M |
| Shares Outstanding | - | 144.30M | 146.82M | 146.82M | 146.82M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 365.00M | 432.00M | 301.00M | 489.00M |
| Investing Cash Flow | - | -196.00M | -216.00M | -313.00M | -309.00M |
| Financing Cash Flow | - | -150.00M | -177.00M | -61.00M | -215.00M |
| Capital Expenditure | - | -289.00M | -366.00M | -413.00M | -330.00M |
| Free Cash Flow | - | 76.00M | 66.00M | -112.00M | 159.00M |
| Net Change in Cash | - | 19.00M | 39.00M | -73.00M | -35.00M |
| Share Buybacks | - | 0 | 0 | 79.00M | 115.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 11.3% | 13.5% | 12.8% | 14.0% |
| Operating Margin % | - | 4.0% | 4.9% | 3.7% | 5.6% |
| Net Margin % | - | 3.6% | 1.9% | 0.8% | 3.2% |
| ROE % | - | 39.3% | 21.2% | 7.9% | 28.7% |
| ROCE % | - | 9.9% | 11.4% | 8.3% | 13.3% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 9.52% | 12.96M | $444.15M |
| 2 | Bpifrance SA | 9.25% | 12.59M | $431.47M |
| 3 | FMR, LLC | 5.11% | 6.96M | $238.51M |
| 4 | T. Rowe Price Investment Management, Inc. | 2.91% | 3.96M | $135.70M |
| 5 | Vanguard Portfolio Management LLC | 2.88% | 3.93M | $134.54M |
| 6 | Millennium Management Llc | 2.55% | 3.47M | $118.89M |
| 7 | Shaw D.E. & Co., Inc. | 2.38% | 3.23M | $110.82M |
| 8 | Arrowstreet Capital, Limited Partnership | 2.37% | 3.23M | $110.59M |
| 9 | Morgan Stanley | 2.35% | 3.20M | $109.50M |
| 10 | Nuveen, LLC | 2.08% | 2.83M | $96.88M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CSTM